Bullboard - Stock Discussion Forum Revance Therapeutics Inc RVNC

Healthcare

Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to... see more

Add To Watchlist

NDAQ:RVNC - Post Discussion

Revance Therapeutics Inc > Revance Announces Pricing of $100.0 Million Public Offering

View:

Post by whytestocks on Mar 04, 2024 6:00pm

Revance Announces Pricing of $100.0 Million Public Offering

Just In: $RVNC Revance Announces Pricing of $100.0 Million Public Offering of Common StockRevance Therapeutics, Inc. (Nasdaq: RVNC) (“Revance” or the “Company”) today announced the pricing of an underwritten public offering of 16,000,000 shares of its common stock. The shares of common stock are being offered at a public offering price of $6.25 per share. T...RVNC - Revance Announces Pricing of $100.0 Million Public Offering of Common Stock